Free tool
Upcoming earnings calendar
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the US in the next 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
663 companies reporting in the next 90 days. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | 1M return | |
|---|---|---|---|---|---|
| Tuesday, Nov 3 · in 68 days · 7 companies | |||||
| LAB | Standard BioTools Inc. | Healthcare | $255.18M | −17.49% | |
| STIM | Neuronetics, Inc. | Healthcare | $227.07M | +60.43% | |
| LFCR | Lifecore Biomedical, Inc. | Healthcare | $176.02M | +5.92% | |
| CPIX | Cumberland Pharmaceuticals Inc. | Healthcare | $130.35M | +69.86% | |
| BMEA | Biomea Fusion, Inc. | Healthcare | $123.95M | ||
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock. Looking for a name that isn't listed? Jump straight to it:
| +36.80% |
| HRTX | Heron Therapeutics, Inc. | Healthcare | $59.27M | −36.29% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | Healthcare | $44.46M | −72.36% |
| Wednesday, Nov 4 · in 69 days · 64 companies | |||||
| MCK | McKesson Corporation | Healthcare | $104.54B | +0.80% | |
| COR | Cencora, Inc. | Healthcare | $62.55B | +2.57% | |
| MDLN | Medline Inc. | Healthcare | $46.53B | −12.02% | |
| RVMD | Revolution Medicines, Inc. | Healthcare | $46.18B | +17.18% | |
| RPRX | Royalty Pharma plc | Healthcare | $35.71B | +3.05% | |
| STE | STERIS plc | Healthcare | $23.09B | +2.79% | |
| CRL | Charles River Laboratories International, Inc. | Healthcare | $14.09B | +22.74% | |
| CORT | Corcept Therapeutics Incorporated | Healthcare | $12.95B | +27.19% | |
| PEN | Penumbra, Inc. | Healthcare | $12.72B | +0.96% | |
| MDGL | Madrigal Pharmaceuticals, Inc. | Healthcare | $12.45B | +0.01% | |
| IONS | Ionis Pharmaceuticals, Inc. | Healthcare | $10.56B | +14.58% | |
| CAI | Caris Life Sciences, Inc. | Healthcare | $7.58B | +72.03% | |
| MIRM | Mirum Pharmaceuticals, Inc. | Healthcare | $5.98B | −12.22% | |
| ACAD | ACADIA Pharmaceuticals Inc. | Healthcare | $5.07B | +13.73% | |
| TNGX | Tango Therapeutics, Inc. | Healthcare | $4.29B | −4.43% | |
| ADPT | Adaptive Biotechnologies Corporation | Healthcare | $4.18B | +16.16% | |
| TARS | Tarsus Pharmaceuticals, Inc. | Healthcare | $3.10B | +19.85% | |
| ACHC | Acadia Healthcare Company, Inc. | Healthcare | $2.85B | −6.45% | |
| CURA.TO | Curaleaf Holdings, Inc. | Healthcare | $2.51B | +8.58% | |
| OCUL | Ocular Therapeutix, Inc. | Healthcare | $2.37B | +27.46% | |
| CLOV | Clover Health Investments, Corp. | Healthcare | $2.26B | −1.96% | |
| ADMA | ADMA Biologics, Inc. | Healthcare | $2.16B | +9.56% | |
| ESTA | Establishment Labs Holdings Inc. | Healthcare | $2.15B | −21.16% | |
| XNCR | Xencor, Inc. Common Stock | Healthcare | $2.11B | +42.41% | |
| SRPT | Sarepta Therapeutics, Inc. | Healthcare | $2.06B | +26.12% | |
| TSHA | Taysha Gene Therapies, Inc. | Healthcare | $1.96B | +10.26% | |
| VIR | Vir Biotechnology, Inc. | Healthcare | $1.87B | +25.20% | |
| RXRX | Recursion Pharmaceuticals, Inc. | Healthcare | $1.87B | +14.43% | |
| TYRA | Tyra Biosciences, Inc. | Healthcare | $1.56B | −15.09% | |
| CNMD | CONMED Corporation | Healthcare | $1.53B | +14.08% | |
| INVA | Innoviva, Inc. | Healthcare | $1.53B | −2.61% | |
| SDGR | Schrödinger, Inc. | Healthcare | $1.46B | +27.34% | |
| ENOV | Enovis Corporation | Healthcare | $1.46B | −14.46% | |
| PNTG | The Pennant Group, Inc. | Healthcare | $1.34B | −8.90% | |
| MNKD | MannKind Corporation | Healthcare | $1.32B | +4.60% | |
| PRCT | PROCEPT BioRobotics Corporation | Healthcare | $1.21B | +16.54% | |
| USPH | U.S. Physical Therapy, Inc. | Healthcare | $1.17B | −0.92% | |
| GERN | Geron Corporation | Healthcare | $995.83M | +5.52% | |
| OABI | OmniAb, Inc. | Healthcare | $699.33M | +144.16% | |
| ZVRA | Zevra Therapeutics, Inc. | Healthcare | $697.17M | +20.66% | |
| AQST | Aquestive Therapeutics, Inc. | Healthcare | $676.51M | +43.35% | |
| ARVN | Arvinas, Inc. | Healthcare | $609.40M | +13.66% | |
| CTKB | Cytek Biosciences, Inc. | Healthcare | $594.02M | +2.47% | |
| EOLS | Evolus, Inc. | Healthcare | $579.92M | +41.16% | |
| SENS | Senseonics Holdings, Inc. | Healthcare | $493.84M | +90.22% | |
| EYPT | EyePoint, Inc. | Healthcare | $430.20M | −58.28% | |
| LXEO | Lexeo Therapeutics, Inc. | Healthcare | $420.90M | +14.12% | |
| UPB | Upstream Bio, Inc. | Healthcare | $390.52M | +11.41% | |
| VMD | Viemed Healthcare, Inc. | Healthcare | $355.36M | −21.73% | |
| VNDA | Vanda Pharmaceuticals Inc. | Healthcare | $323.48M | +3.68% | |
| ANIK | Anika Therapeutics, Inc. | Healthcare | $290.14M | +43.10% | |
| RXST | RxSight, Inc. | Healthcare | $265.36M | +5.45% | |
| OSUR | OraSure Technologies, Inc. | Healthcare | $255.87M | −7.71% | |
| KROS | Keros Therapeutics, Inc. | Healthcare | $220.48M | +10.43% | |
| AMWL | American Well Corporation | Healthcare | $199.17M | +7.48% | |
| LENZ | LENZ Therapeutics, Inc. | Healthcare | $146.73M | −18.71% | |
| ALDX | Aldeyra Therapeutics, Inc. | Healthcare | $93.51M | −1.27% | |
| ECOR | electroCore, Inc. | Healthcare | $93.31M | +69.95% | |
| GOSS | Gossamer Bio, Inc. | Healthcare | $85.01M | −15.17% | |
| SCYX | SCYNEXIS, Inc. | Healthcare | $56.41M | +56.20% | |
| BTMD | biote Corp. | Healthcare | $52.54M | −30.80% | |
| MCRB | Seres Therapeutics, Inc. | Healthcare | $47.81M | −0.83% | |
| ARAY | Accuray Incorporated | Healthcare | $31.57M | +10.12% | |
| LGVN | Longeveron Inc. | Healthcare | $21.68M | +17.02% | |
| Thursday, Nov 5 · in 70 days · 29 companies | |||||
| CGN.DE | The Cigna Group | Healthcare | $74.86B | −9.42% | |
| CI | The Cigna Group | Healthcare | $74.22B | −6.71% | |
| MRNA | Moderna, Inc. | Healthcare | $59.75B | +168.18% | |
| 0QF.DE | Moderna, Inc. | Healthcare | $59.07B | +181.04% | |
| CAH | Cardinal Health, Inc. | Healthcare | $55.45B | +2.53% | |
| BOX.DE | Becton, Dickinson and Company | Healthcare | $51.84B | +23.08% | |
| BDX | Becton, Dickinson and Company | Healthcare | $51.81B | +14.35% | |
| NTRA | Natera, Inc. | Healthcare | $48.53B | +34.19% | |
| VIA.DE | Viatris Inc. | Healthcare | $19.41B | −9.28% | |
| VTRS | Viatris Inc. | Healthcare | $19.35B | −5.66% | |
| ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | $19.34B | +5.88% | |
| SOLV | Solventum Corporation | Healthcare | $15.58B | +6.22% | |
| ELAN | Elanco Animal Health Incorporated | Healthcare | $12.53B | −1.72% | |
| GMED | Globus Medical, Inc. | Healthcare | $11.16B | +3.13% | |
| CYTK | Cytokinetics, Incorporated | Healthcare | $11.01B | −0.31% | |
| PODD | Insulet Corporation | Healthcare | $9.94B | −14.38% | |
| PTGX | Protagonist Therapeutics, Inc. | Healthcare | $9.80B | +10.71% | |
| CRNX | Crinetics Pharmaceuticals, Inc. | Healthcare | $9.00B | +1.17% | |
| TXG | 10x Genomics, Inc. | Healthcare | $8.37B | +36.58% | |
| LNTH | Lantheus Holdings, Inc. | Healthcare | $6.58B | −1.77% | |
| DNTH | Dianthus Therapeutics, Inc. | Healthcare | $6.13B | +9.01% | |
| PTCT | PTC Therapeutics, Inc. Common Stock | Healthcare | $6.07B | −3.58% | |
| RDNT | RadNet, Inc. | Healthcare | $6.05B | +20.96% | |
| DFTX | Definium Therapeutics, Inc. | Healthcare | $5.88B | +4.31% | |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | $5.74B | −2.85% | |
| DYN | Dyne Therapeutics, Inc. | Healthcare | $4.92B | +1.78% | |
| HAE | Haemonetics Corporation | Healthcare | $4.85B | +29.15% | |
| EWTX | Edgewise Therapeutics, Inc. | Healthcare | $4.80B | +9.99% | |
| LFST | LifeStance Health Group, Inc. | Healthcare | $4.69B | +8.10% | |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India). Reporting dates are public estimates and can shift.